Cargando…
Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment
SIMPLE SUMMARY: Cell-based therapies composed of genetically engineered immune cells have huge potential for treating cancer. T cells modified to express tumour-targeting receptors have been proven to be highly effective against blood cancers but not solid malignancies. Using innovative genetic modi...
Autores principales: | Fowler, Daniel, Nattress, Callum, Navarrete, Alba Southern, Barisa, Marta, Fisher, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657158/ https://www.ncbi.nlm.nih.gov/pubmed/34885108 http://dx.doi.org/10.3390/cancers13236000 |
Ejemplares similares
-
Interplay between γδT-Cell Metabolism and Tumour Microenvironment Offers Opportunities for Therapeutic Intervention
por: Barisa, Marta, et al.
Publicado: (2021) -
Immune‐mediated ECM depletion improves tumour perfusion and payload delivery
por: Yeow, Yen Ling, et al.
Publicado: (2019) -
Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles
por: Kim, Byoungjin, et al.
Publicado: (2010) -
Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles
por: Shazly, Tarek, et al.
Publicado: (2022) -
Engineered hapten‐binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery
por: Dengl, Stefan, et al.
Publicado: (2016)